MedTrace Logo

Efficacy and Safety of Single, Low-dose Dexamethasone in Patients After Total Knee Arthroplasty

NCT01612702 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 291

Last updated 2013-05-27

Study results available
· View outcomes & findings →

Summary

This study was conducted to determine the efficacy of an additional preemptive, single, low-dose dexamethasone in terms of incidence and severity of postoperative nausea/vomiting (PONV), pain level, and the safety in terms of wound complications in patients managed with our antiemetic protocol based on Ramosetron following TKA.

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Dexamethasone

Dexamethasone 10 mg intravenous administration

Sponsors & Collaborators

  • Tae Kyun Kim

    lead OTHER

Principal Investigators

  • T K Kim, MD, PhD · Joint Recontruction Center, Seoul National University Bundang hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2012-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612702 on ClinicalTrials.gov